Human endotoxin administration as an experimental model in drug development.

Suffredini, A F; Noveck, R J

Suffredini, A F; Noveck, R J.

Affiliation

Suffredini AF; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Noveck RJ; Department of Medicine, Division of Clinical Pharmacology, Duke Clinical Research Unit, Duke University School of Medicine, Durham, North Carolina, USA.

Clin Pharmacol Ther ; 96(4): 418-22, 2014 Oct.

Article in En | MEDLINE | ID: mdl-25236665

Subject(s)

Anti-Inflammatory Agents/chemistry; Drug Discovery/methods; Endotoxins; Infections/chemically induced; Inflammation/chemically induced; Anti-Inflammatory Agents/therapeutic use; Endotoxins/administration & dosage; Humans; Infections/drug therapy; Infections/immunology; Inflammation/drug therapy; Inflammation/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endotoxins / Drug Discovery / Infections / Inflammation / Anti-Inflammatory Agents Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2014 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google